EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, SANUWAVE Health's enterprise value is $53.18 Mil.
SANUWAVE Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $20.40 Mil. Therefore, SANUWAVE Health's EV-to-Revenue for today is 2.61.
The historical rank and industry rank for SANUWAVE Health's EV-to-Revenue or its related term are showing as below:
SNWV'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.83 Med: 18.22 Max: 116.04
Current: 2.61
During the past 13 years, the highest EV-to-Revenue of SANUWAVE Health was 116.04. The lowest was 1.83. And the median was 18.22.
SNWV's EV-to-Revenue is ranked better than 52.36% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 3
vs SNWV: 2.61
As of today (2024-04-24), SANUWAVE Health's stock price is $0.022.
SANUWAVE Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.03. Therefore, SANUWAVE Health's PS Ratio for today is 0.81.
SANUWAVE Health EV-to-Revenue Historical Data
The historical data trend for SANUWAVE Health's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, SANUWAVE Health's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SANUWAVE Health EV-to-Revenue Distribution
For the Medical Devices & Instruments industry and Healthcare sector, SANUWAVE Health's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where SANUWAVE Health's EV-to-Revenue falls into.
SANUWAVE Health's current Enterprise Value is $53.18 Mil.
SANUWAVE Health's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $20.40 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health (OTCPK:SNWV) EV-to-Revenue Explanation
SANUWAVE Health's share price for today is $0.022.
SANUWAVE Health's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SANUWAVE Health EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of SANUWAVE Health's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
SANUWAVE Health (SANUWAVE Health) Business Description
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SNWV has been successfully added to your 